Literature DB >> 19841179

A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.

Chul Won Choi1, Yang Jo Chung, Christopher Slape, Peter D Aplan.   

Abstract

Expression of a NUP98-HOXD13 (NHD13) fusion gene leads to myelodysplastic syndrome in mice. In addition to ineffective hematopoiesis, we observed that NHD13 mice were lymphopenic; the lymphopenia was due to a decrease in both T and B lymphocytes. Although the pro-B cell (B220(+)/CD43(+)) populations from the NHD13 and wild-type mice were similar, the NHD13 mice showed decreased pre-B cells (B220(+)/CD43(-)), indicating impaired differentiation at the pro-B to pre-B stage. Thymi from NHD13 mice were smaller and overexpressed Hoxa cluster genes, including Hoxa7, Hoxa9, and Hoxa10. In addition, the NHD13 thymi contained fewer thymocytes, with an increased percentage of CD4(-)/CD8(-) (double-negative (DN)) cells and a decreased percentage of CD4(+)/CD8(+) (double-positive) cells; the DN1/DN2 population was increased and the DN3/DN4 population was decreased, suggesting a partial block at the DN2 to DN3 transition. To determine clonality of the thymocytes, we used degenerate RT-PCR to identify clonal Tcrb gene rearrangements. Five of six NHD13 thymi showed an unusual Tcrb gene rearrangement pattern with common, clonal DJ rearrangements, but distinct V-D junctions, suggesting a marked clonal expansion of thymocytes that had undergone a DJ rearrangement, but not completed a VDJ rearrangement. Taken together, these findings demonstrate that expression of the NHD13 transgene inhibits lymphoid as well as myeloid and erythroid differentiation, results in overexpression of Hoxa cluster genes, and leads to a precursor T cell lymphoblastic leukemia/lymphoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841179      PMCID: PMC3422874          DOI: 10.4049/jimmunol.0901121

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor.

Authors:  Tom Taghon; Frank Stolz; Magda De Smedt; Maggy Cnockaert; Bruno Verhasselt; Jean Plum; Georges Leclercq
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

Review 2.  Methods for detecting apoptosis in thyroid diseases.

Authors:  R Mirakian; K Nye; F F Palazzo; A W Goode; L J Hammond
Journal:  J Immunol Methods       Date:  2002-07-01       Impact factor: 2.303

3.  Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells.

Authors:  Daniella M Bahia Kerbauy; Vladimir Lesnikov; Beverly Torok-Storb; Eileen Bryant; H Joachim Deeg
Journal:  Blood       Date:  2004-10-01       Impact factor: 22.113

4.  Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.

Authors:  Unnur Thorsteinsdottir; Aline Mamo; Evert Kroon; Lori Jerome; Janet Bijl; H Jeffrey Lawrence; Keith Humphries; Guy Sauvageau
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  Somatic recombination in a murine T-cell receptor gene.

Authors:  Y H Chien; N R Gascoigne; J Kavaler; N E Lee; M M Davis
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

6.  scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.

Authors:  D S Chervinsky; D H Lam; M P Melman; K W Gross; P D Aplan
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

7.  Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes.

Authors:  K Dannaeus; A Johannisson; K Nilsson; J I Jönsson
Journal:  Exp Hematol       Date:  1999-11       Impact factor: 3.084

8.  Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.

Authors:  Yang Jo Chung; Chul Won Choi; Christopher Slape; Terry Fry; Peter D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

9.  Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.

Authors:  Nicolas Pineault; Christian Buske; Michaela Feuring-Buske; Carolina Abramovich; Patty Rosten; Donna E Hogge; Peter D Aplan; R Keith Humphries
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

Review 10.  The many important facets of T-cell repertoire diversity.

Authors:  Janko Nikolich-Zugich; Mark K Slifka; Ilhem Messaoudi
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

View more
  13 in total

1.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

2.  Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.

Authors:  Sarah H Beachy; Masahiro Onozawa; Deborah Silverman; Yang Jo Chung; Mariela Martinez Rivera; Peter D Aplan
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

Review 3.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

Review 4.  Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.

Authors:  Jerrold M Ward; Jerold E Rehg; Herbert C Morse
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

Review 5.  Mouse models of myelodysplastic syndromes.

Authors:  Sarah H Beachy; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

6.  The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

Authors:  Jesslyn Saw; David J Curtis; Damian J Hussey; Alexander Dobrovic; Peter D Aplan; Christopher I Slape
Journal:  Leuk Res       Date:  2013-09-21       Impact factor: 3.156

7.  Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.

Authors:  Rachel L Novak; David P Harper; David Caudell; Christopher Slape; Sarah H Beachy; Peter D Aplan
Journal:  Exp Hematol       Date:  2012-08-08       Impact factor: 3.084

8.  Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome.

Authors:  Abdul Gafoor Puthiyaveetil; Christopher M Reilly; Timothy S Pardee; David L Caudell
Journal:  Leuk Res       Date:  2012-11-04       Impact factor: 3.156

9.  Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.

Authors:  Sheryl M Gough; Yang Jo Chung; Peter D Aplan
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

10.  Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.

Authors:  Liat Goldberg; Vijay Negi; Yang Jo Chung; Masahiro Onozawa; Yuelin J Zhu; Robert L Walker; Rachel Pierce; Daxesh P Patel; Kristopher W Krausz; Frank J Gonzalez; Margaret A Goodell; Benjamin A T Rodriguez; Paul S Meltzer; Peter D Aplan
Journal:  Cancer Res       Date:  2021-07-28       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.